
Amanda Nizam, MD
@amandanizammd
GU Medical Oncologist @ClevelandClinic | Bladder, kidney, & prostate Ca | Tx-related toxicity | @ASCOTECAG & @GWSMHS alum | đ citizen | Views my own | COI âŹď¸
ID: 106342723
https://coi.asco.org/share/VF7-WR44/Amanda%20Nizam 19-01-2010 07:22:54
4,4K Tweet
1,1K Followers
1,1K Following







We previously reported on how a DOGE staffer with no government or health care experience created an AI tool to mark VA contracts as âmunchable.â Among the contracts it canceled: critical projects to help improve cancer treatment and nursing care. propublica.org/article/doge-vâŚ


New editorial led by Robin Yabroff comments on a recent report finding that up-to-date colorectal cancer screening increased most in Medicaid expansion states w/ paid leave laws relative to nonexpansion states w/o paid leave laws. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn⌠OncoAlert


We have life saving cancer drugs and life threatening shortages. âŚJulie GralowâŠ, ASCO⊠staff, and I discuss why, and potential solutions in âŚJCO Oncology PracticeâŠ: ascopubs.org/doi/10.1200/OPâŚ

âCongress is about to impose immense harm on tens of millions of Americansâtaking away their health insurance, reducing welfare benefits, raising energy costs, and moreâin order to benefit a handful of other Americans who least need the helpâ theatlantic.com/politics/archiâŚ


đ Now enrolling MD Anderson Cancer Center: IVORY trial of #ivonescimab (first-in-class PD1ĂVEGF bispecific) in metastatic clear cell #KidneyCancer after prior IOÂąTKI. Hypothesis: cooperative inhibition of PD1/VEGF signaling will restore treatment sensitivity đ clinicaltrials.gov/study/NCT06940âŚ


ctDNA can help guide adjuvant decision making in MIBC In pts with undetectable ctDNA after NAC + cystectomy, no definitive benefit for adjuvant ICB authors.elsevier.com/c/1lMET14kpm0h⌠Matt Galsky The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Uromigos Bladder Cancer Advocacy Network UroToday.com World Bladder Cancer Patient Coalition OncLive.com




âDespite our flawed instinct to take the path of least resistance,â writes Dr. Arthur Brooks of Cicero's great life lesson, âwe will always be better served by choosing to do the right thingâ: theatlantic.com/ideas/archive/âŚ

đââď¸Hello!! How's your schedule this fall? đ#WomenInOncology, save Sep 27-28 for #LEAD25! It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology! đ bioascend.com/lead/ Dr. Julie Brahmer Ana I. VelĂĄzquez MaĂąana, MD, MSc, FASCO Dr. Catherine Lai

